Upload
others
View
19
Download
0
Embed Size (px)
Citation preview
28/05/2018
1
Matteo Gastaldi
Neuroimmunology laboratory
IRCCS C Mondino
Autoimmune EncephalitisFrom laboratory approach to clinical
management
Pavia, 25/5/2018
paraneoplastic neurological syndromes
• Anti-Hu
• Anti-Yo
• Anti-Ri
• Anti-CV2
• Anti-Ma2
• Anti-Amphyphysin
etc.
neurological syndromes of unknown cause often associated with tumor
Yo
immunofluorescence on rat cerebellum
intracellular protein targetsthat are not accessible in vivo
the autoantibody, detectable with
conventional techniques, is just a
BIOMARKER of disease (>80% of patients)
ONCONEURAL ANTIBODIESGraus F et al., Neurology 1985;35:538
28/05/2018
2
• target surface antigens (usually synaptic proteins)
• can be pathogenetic (directly responsible for synaptic dysfunction)
• neurological syndromes (mainly ENCEPHALITIS) respond to
immunotherapies
SEIZURES
PSYCHIATRIC
DYSAUTONOMIA
PNS INVOLVEMENT
GASTROENTERIC
MOVEMENT DISORDERS
HYPOTALAMIC DYSFUNCTON
COGNITIVE
Neuronal cell surface antibodies
Target antigen Year Age at presentation NMDAR 2007 Adults>/= Children Glycine R 2008 Adults >>Children AMPAR 2009 Adults GABA-B R 2010 Adults>>Children LGI1/CASPR2 2010 Adults mGluR5 2011 Adults=Children Dopamine-2 R 2012 Children DPPX 2013 Adults >>> Children GABA-A R 2014 Adults=Children IgLON5 2014 Adults Neurexin-3α 2016 Adults
the expanding field of autoimmune encephalitisfrequency in adults vs children
Gastaldi M et al. Expert Rev Mol Diagn 2018;18:181
28/05/2018
3
Several years PD diagnosis
Subacute worsening of
extrapiramidal function with
fever and pneumonia
Persistent behavioral alteration
(apathy, anorexia)
Cognitive alteration?
NMDAR encephalitis
Courtesy of Voghera neurology department (Carla Arbasino)
NMDAR Abs in serum and CSF
a. Linear epitopes are short and continuous, and after denaturation they are still be
able to bind the antibody (‘traditional’ methods for antibody detection are denaturing)
b. Conformational epitopes are discontinuous and depend on the higher order of
the protein structure, and after denaturation they can no longer bind the antibody
how antibodies
work:
schematic
representation of
two antibodies
interacting with
linear or
conformational
epitopes
Laboratory diagnostic for autoimmune encephalitis
28/05/2018
4
AUTOIMMUNE ENCEPHALITIS: laboratory diagnostic tools
CELL BASED ASSAY
commercial fixed CBA (Euroimmun)
“MOSAIC”:NMDAR
LGI1
Caspr2
GABAB
AMPAR1-2
• Limited number of antigens included
• Possible suboptimal performance
Clinical Biochemistry
Volume 50, Issue 6, April 2017, Pages 354-355
Pitfalls in the detection of N-methyl-D-aspartate-receptor (NMDA-R) antibodies
Ma eo Gastaldi, Anaïs Thouin, Diego Francio a,
Angela Vincent
NON-ANTIGEN SPECIFIC method, but some
antigen-specific patterns can be recognized
standard methods for tissue fixation do not
work: LIGHT FIXATION allows the preservation
of the antigen conformation
R
• Many known antibodies can be identified
• “Uncharacterized reactivities” (Novel antigens?)
AUTOIMMUNE ENCEPHALITIS: laboratory diagnostic tools
IMMUNOHISTOCHEMISTRY ON RAT BRAIN
28/05/2018
5
SURFACE
ANTIGEN
ACCESSIBLE
IN-VIVO
Abs ARE LIKELY TO BE
RELEVANT/PATHOGENETIC
NEURONS ALSO PROVIDE A SUITABLE SUBSTRATE FOR IMMUNOPRECIPITATION
AND NEW ANTIGEN IDENTIFICATION
no light fixation
AUTOIMMUNE ENCEPHALITIS: laboratory diagnostic tools
PRIMARY NEURONAL CULTURES
Gastaldi M et al. Expert Rev Mol Diagn 2018;18:181
• 2 step approach
(First/Second level
diagnostics)
• In second level
diagnostic, at least 2
methods should be used
28/05/2018
6
Antibodies are so important…….
……… that we have to stop relying on them!
�Long turnaround time of antibody results (months)
�Lack of standardization (likely suboptimal first level diagnostic)
�WHAT to test? (“Panel” of anti-CNS antibodies)
�HOW to interpret antibody results (Sensitivity/specificity of
single tests)
Case report
- tiredness, irritability
- episodes of falling asleep during the day
- lingual movements when doing enjoyable activities, such as
playing
- NMDAR-Abs on serum (Live CBA)
- CSF unremarkable
- No improvement with steroids and IvIG. Additional immune
theraphy reccomended but not performed
- FINAL DIAGNOSIS: NARCOLEPSY/CATAPLEXY
Armangue et al, Neurology 2015
28/05/2018
7
1) POSSIBLE AUTOIMMUNE ENCEPHALITIS
2) PROBABLE/DEFINITE AUTOIMMUNE ENCEPHALITIS
1) Specific clinical/paraclinical profile (Limbic, NMDAR,
ADEM, Hashimoto, Bickerstaff)
AND/OR
2) Abs presence
3) PROBABLE Ab-NEGATIVE AUTOIMMUNE ENCEPHALITIS
Possible Autoimmune encephalitis
Treatment can be started without abs confirmation
Subacute onset of
• Memory impairment
• Psychiatric symptoms
+
Evidence of inflammation in
- CSF
- MRI
- Brain biopsy
28/05/2018
8
Probable seronegative Autoimmune encephalitis
Diagnosis can be made without antibodies
Subacute onset of
• Memory impairment
• Psychiatric symptoms
+
Evidence of inflammation in
(at least 2)
- CSF
- MRI
- Brain biopsy
Rituximab in seronegative Autoimmune encephalitis
Ab negative ALE show similar response to rituximab compared to synaptic abs and paraneoplastic ALE
Lee et al, Neurology 2016
28/05/2018
9
Application of 2016 criteria for
Autoimmune Encephalitis in clinical
practice:
Italian retrospective study on
Autoimmune Encephalitis
PAVIA
IRCCS C Mondino
OSM San Matteo
MILANO
Ospedale Buzzi
GENOVA
Ospedale San Martino
Istituto Gaslini
FIRENZE
Ospedale Careggi
ROMA
Policlinico Gemelli
Ospedale Pediarico Bambin Gesu’
VERONA
Dipartimento di Neuroscienze
PADOVA
Ospedale Sant’Antonio
Clinica pediatrica
PERUGIA
Ospedale S.Maria della Misericordia
CITTA’ DI CASTELLO
Ospedale di Citta’ di Castello
…WORK IN PROGRESS…
12 hospitals in 9 cities
28/05/2018
10
Possible autoimmune encephalitis
Recruitment 2012�2016
Probable/Definite autoimmune encephalitis
Ab POSITIVE
autoimmune encephalitis
Ab NEGATIVE
autoimmune encephalitis
83 pts72% adults
28% pediatrics
56 pts- 50% NMDAR encephalitis
- 34% Limbic encephalitis
- 16% other (e.g.: status
epilepticus, movement
disorder..)
27 pts- 33%limbic encephalitis
Total=57
NMDARLGI1Caspr2Other antibodiesUncharacterized
30 (52%)
11 (19%)
5 (9%)
6 (10%)
5 (9%)GABA-B (n=1)
GABA-A (n=1)
IgLON5 (n=1)
GLY-R (n=1)
AMPAR (n=1)
6/7 binding to live
neurons
Neuronal surface antibodies in Definite AE
28/05/2018
11
AIMS:
- clinical profile, outcome and response to
immunotherapy of Ab NEGATIVE
AUTOIMMUNE ENCEPHALITIS
- Comparison of Adult vs pediatric population
- Novel antigen discovery
THANKS FOR YOUR ATTENTION
Diego Franciotta (Pavia)
Elisabetta Zardini (Pavia)
Silvia Scaranzin (Pavia)
Laboratorio Neuroimmunologia- IRCCS C Mondino
28/05/2018
12
Courtesy of prof. Angela Vincent
detection of Abs to neuronal cell-surface antigens
neuronal surface Abs are
‘conformational’, and antigen
degradation/denaturation
prevents their detection with
‘common’ methods
dot blot
nitrocellulose
Antigen
Western blot
ELISA
conformational
antigen
degradation
nitrocellulose
polyvinyl or polystyrene
28/05/2018
13
1 & 2) CELL-BASED ASSAY on live or fixed cells
live (native antigen) fixed (antigen denaturation)
which advantages of
using in-house live vs
fixed CBAs?
- more 'native' antigens
- no reactivity to
intracellular antigens
(fixed cells allow Abs to
enter the cell)
cDNA-plasmid vector
which advantages
of using live vs
fixed CBAs?
the widely
available
commercial tests
are necessarily
fixed
28/05/2018
14
some antigen-specific patterns can be recognized(confirmation with CBAs, live or fixed, is mandatory)
3) IMMUNOHISTOCHEMISTRY ON RAT BRAIN
Neuroimmunology Laboratory, Mondino National Neurological Institute, Pavia
R
R
false positive result on NMDAR-transfected cells(commercial CBA)
negative
true positive
Neuroimmunology Lab., Mondino, Pavia, Italy
Clinical Biochemistry
Volume 50, Issue 6, April 2017, Pages 354-355
Pitfalls in the detection of N-methyl-D-aspartate-receptor (NMDA-R) antibodies
Matteo Gastaldi, Anaïs Thouin, Diego Franciotta,
Angela Vincent
28/05/2018
15
Presentation outline
• Introduction on autoimmune encephalitis and
Neuronal surface antibodies
• Laboratory diagnostic of autoimmune
encephalitis
• Clinical criteria for autoimmune encephalitis
• Retrospective study on autoimmune
encephalitis